Axiomatics’ pharmaceutical customers no longer need to lock down R&D data. They are able to share sensitive information with external laboratories and suppliers. In fact, according to one Fortune 500 pharmaceutical company, this ability is leading to the design and production of a number of new molecules and drugs, which simply wouldn’t have been possible without multi-dimensional authorization.

Read more about how ABAC can help securely share the right data across applications and data stores.